Search clinical trials for: Pneumovax

Total 123 results

Institut National de la Santé Et de la Recherche...

Completed

Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response (PNEUMOVACB)

Pneumococcal Diseases

France
Assistance Publique - Hôpitaux de Paris
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne; EUCLID Clinical... and other collaborators

Active, not recruiting

Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients. (SPLENEVAC-2)

Splenectomised Patients

France
Cedars-Sinai Medical Center

Completed

Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis | Inflammatory Bowel Disease

United States
Far Eastern Memorial Hospital

Completed

PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

Taiwan
Kameda Medical Center
Merck Sharp & Dohme LLC; PPD; Osaka University

Completed

The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine

Influenza | Pneumococcal Pneumonia

Japan
Sheba Medical Center

Unknown

Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients

Ataxia Telangiectasia

Israel
University of California, Davis

Recruiting

Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

Asplenia

United States
KEMRI-Wellcome Trust Collaborative Research Program

Completed

Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)

Pneumonia, Pneumococcal

Kenya
Mayo Clinic

Completed

Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine

Healthy

United States
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease (PNEUMO)

Pulmonary Disease, Chronic Obstructive

United States
Mayo Clinic

Completed

Pneumococcal Vaccines in Patients With Asthma

Asthma

United States
Immune Response BioPharma, Inc.
cro

Recruiting

A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis

Multiple Sclerosis | Secondary Progress Multiple Sclerosis

United States
Kaiser Permanente
Centers for Disease Control and Prevention

Completed

Pneumococcal Adult-dose Ranging Immunization Study

Pneumonia

United States
CIHR Canadian HIV Trials Network
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Early Versus Delayed Pneumococcal Vaccination in HIV

Pneumococcal Infections

Canada
GlaxoSmithKline

Completed

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

Belgium
Merck Sharp & Dohme LLC

Completed

A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)

Pneumococcal Disease
National Institute of Allergy and Infectious Diseases...

Completed

Pneumococcal Reference Standard

Pneumococcal Infections

United States
University of Alabama at Birmingham
Hospital for Special Surgery, New York

Completed

BLYS and IFN in SLE

Systemic Lupus Erythematosus

United States
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)

Herpes Zoster | Pneumococcal Infection
Yubari Kibounomori
Health Research Foundation

Completed

Effects of the Oral Care With Vaccines for Pneumonia in Elderly; Going Home Together Both Physician and Dentist

Pneumonia

Japan
Helsinki University Central Hospital
Tampere University Hospital

Completed

Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients (SOT13)

Liver Transplantation | Kidney Transplantation

Finland
Karolinska University Hospital

Completed

Pneumococcal Vaccine in Untreated CLL Patients

Chronic Lymphocytic Leukemia

Sweden
University of Melbourne
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Pneumococcal Vaccination of Fiji Infants

Pneumococcal Infections

Fiji
University of California, San Diego
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Perturbing of HIV Reservoir With Immune Stimulation

HIV | AIDS

United States
GPN Vaccines

Recruiting

Extension Safety and Immunogenicity Study of GPNV-001

Pneumococcal Infections

Australia
Mayo Clinic

Completed

A Study to Evaluate Pneumococcal Polysaccharide Vaccine Effectiveness in Children With Type 1 Diabetes

Type 1 Diabetes

United States
Assistance Publique - Hôpitaux de Paris
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne; EUCLID Clinical... and other collaborators

Completed

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy (PNEUMOVAS)

Invasive Pneumococcal Infection

France
argenx

Completed

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

Healthy Volunteers

Netherlands
GlaxoSmithKline

Completed

Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.

Streptococcus Pneumoniae Vaccines

Sweden
Merck Sharp & Dohme LLC

Completed

Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)

Pneumococcal Infection
University of Oxford
Mason Medical Research Trust

Completed

Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines

Pneumococcal Disease

United Kingdom
National Institute on Aging (NIA)

Completed

PPV: Pneumococcal Polysaccharide Vaccine in Older Adults

Aging

United States
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults

Pneumococcal Disease

United States, Sweden
Merck Sharp & Dohme LLC

Completed

Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)

Pneumococcal Infection
Menzies School of Health Research
National Health and Medical Research Council, Australia

Completed

PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers (PneuMum)

Pneumococcal Infections | Tympanic Membrane Perforation | Acute Otitis Media | Middle Ear Effusion

Australia
Pfizer

Completed

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

Pneumococcal Disease

Korea, Republic of, Taiwan, Japan
National Institute of Allergy and Infectious Diseases...

Terminated

Antibody Production in Immune Disorders

Primary Immune Deficiency

United States
Uppsala University

Completed

Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery

Meningitis
GlaxoSmithKline
Affinivax, Inc.

Completed

A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine

Pneumonia, Bacterial | Healthy Volunteers | Pneumococcal Disease

United States
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses

Pneumococcal Infections | HIV | Pneumococcal Vaccines

United States
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Pneumococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)

Pneumococcal Infections

United States, Australia, Canada, Chile, New Zealand, Poland, Russian Federation
Helsinki University Central Hospital

Completed

Targeting of Immune Response After Pneumococcal Vaccination (PncHR)

Pneumococcal Pneumonia

Finland
GPN Vaccines

Recruiting

Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

Pneumococcal Infections

Australia
Jena University Hospital

Completed

Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels

Pneumococcal Infections

Germany
Merck Sharp & Dohme LLC

Completed

Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)

Pneumococcal Infections
Statens Serum Institut
Hvidovre University Hospital; Herlev Hospital

Completed

Pneumococcal Vaccination of Crohn Patients (PneuVAC)

Crohns Disease

Denmark
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4)

Pneumococcal Disease

United States, Austria, Canada, Denmark, Finland, Israel, Poland, Spain
University of Florida

Completed

Effect of Obesity on Immune Response to Pneumovax 23 (ROVE)

Obesity

United States
Liverpool School of Tropical Medicine
Pfizer

Recruiting

PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2) (Pneumo 2)

Streptococcus Pneumonia

United Kingdom

Search clinical trials for: Pneumovax

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations